SCHEMBL1784941

SCHEMBL1784941

CCC(C)CCC(C)C=O

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28439 0.85 TSHR (0.38) TSHRSMN1; SMN2
SCHEMBL1784030 0.85 TSHR (0.38) TSHRSMN1; SMN2
SCHEMBL19270734 0.85 TSHR (0.33) TSHRSMN1; SMN2
SCHEMBL9421039 0.83 LMNA (0.39) TSHRSMN1; SMN2
SCHEMBL27456152 0.83 LMNA (0.39) TSHRSMN1; SMN2
SCHEMBL10522453 0.83 TSHR (0.34) TSHRSMN1; SMN2
SCHEMBL1781720 0.82 TSHR (0.40) TSHRSMN1; SMN2
SCHEMBL28156668 0.79 TSHR (0.36) TSHRSMN1; SMN2
SCHEMBL1785163 0.78 TSHR (0.46) TSHRSMN1; SMN2
SCHEMBL4777297 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12246310-B2 Processes for recovery of rhodium from a hydroformylation process DOW TECHNOLOGY INVESTMENTS LLC (US) 2025-03-11 US disclosed
EP-4054762-B1 PROCESSES FOR RECOVERY OF RHODIUM FROM A HYDROFORMYLATION PROCESS DOW TECHNOLOGY INVESTMENTS LLC (US) 2024-12-18 EP disclosed
US-20230406801-A1 PROCESSES TO IMPROVE CATALYTIC METAL ACCOUNTABILITY IN HYDROFORMYLATION PROCESSES DOW TECHNOLOGY INVESTMENTS LLC (US) 2023-12-21 US disclosed
CN-113179638-B Hydroformylation process 陶氏技术投资有限责任公司 2023-11-28 CN disclosed
EP-4259598-A1 PROCESSES TO IMPROVE CATALYTIC METAL ACCOUNTABILITY IN HYDROFORMYLATION PROCESSES Dow Technology Investments LLC (US) 2023-10-18 EP disclosed
CN-116635362-A Method for improving the metering of catalytic metals in hydroformylation processes 陶氏技术投资有限责任公司 2023-08-22 CN disclosed
US-11691936-B2 Hydroformylation process DOW TECHNOLOGY INVESTMENTS LLC (US) 2023-07-04 US disclosed
EP-3887348-B1 HYDROFORMYLATION PROCESS DOW TECHNOLOGY INVESTMENTS LLC (US) 2022-11-02 EP disclosed
US-20220288574-A1 PROCESSES FOR RECOVERY OF RHODIUM FROM A HYDROFORMYLATION PROCESS UNION CARBIDE CORPORATION 2022-09-15 US disclosed
EP-4054762-A1 PROCESSES FOR RECOVERY OF RHODIUM FROM A HYDROFORMYLATION PROCESS Dow Technology Investments LLC (US) 2022-09-14 EP disclosed
CN-104395264-A Isononylamine from 2-ethylhexanol, preparation processe thereof and uses therof OXEA GMBH 2015-03-04 CN disclosed
US-8632792-B2 Cooling sensation agent composition and sensory stimulation agent composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2014-01-21 US disclosed
US-20110117147-A1 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-05-19 US disclosed
WO-2009123355-A2 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-10-08 WO disclosed
US-7186782-B2 Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer TSRC CORPORATION (TW) 2007-03-06 US disclosed
US-20060041079-A1 Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer TSRC CORPORATION 2006-02-23 US disclosed
US-6881797-B2 Process for hydrogenation of conjugated diene polymer TSRC CORPORATION (TW) 2005-04-19 US disclosed
US-20040082727-A1 Process for hydrogenation of conjugated diene polymer TSRC CORPORATION (CN) 2004-04-29 US disclosed
US-5998635-A CATALYTIC CYCLIZATION AN ALDEHYDE WITH A KETENE TAKASAGO INTERNATIONAL CORPORATION (JP) 1999-12-07 US disclosed
US-4021461-A INSECTICIDES ZOECON CORPORATION (US) 1977-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110117147-A1 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TRPA1, HRH1, HRH2 TSHR 2479/4885SMN1; SMN2 2144/4885
US-11691936-B2 Hydroformylation process RTF1, EHMT2, NUDT1 TSHR 3398/4885SMN1; SMN2 605/4885
US-20230406801-A1 PROCESSES TO IMPROVE CATALYTIC METAL ACCOUNTABILITY IN HYDROFORMYLATION PROCESSES RTF1, PYM1, CYP4F11 TSHR 2999/4885SMN1; SMN2 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.